Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03076034 · ClinicalTrials.gov registry record · NA

Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk

A NA study of Osteoporosis and Hip Fractures, sponsored by Beth Israel Deaconess Medical Center.

Active
Registry status
NA
Development phase
190
Enrollment target
1
Study location

NCT03076034 is a NA study of Osteoporosis and Hip Fractures that is active but no longer recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 190 participants, below the 1,544-participant average among 84 other Osteoporosis trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03076034, a NA study of Osteoporosis and Hip Fractures, is active but no longer recruiting, sponsored by Beth Israel Deaconess Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
190 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine whether a new minimally invasive method for in vivo measurement of cortical bone tissue properties can identify those who are at risk for fragility fractures of the hip and radius. The investigators hypothesis is that women with fragility fractures of the hip and radius have altered cortical bone tissue properties compared to non-fracture controls independent of standard clinical tests, such as bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA).

Interventions

  • DEVICE Reference Point Indentation

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2015-01-26
Est. Completion 2028-11
Phase NA

What the Registry Record Tells You About NCT03076034

The ClinicalTrials.gov registry entry for NCT03076034 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,544-participant average among 84 other Osteoporosis trials with a reported enrollment target (88% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which Reference Point Indentation is the first listed.

NCT03076034 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03076034 about?

NCT03076034 is a clinical study titled "Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk". The objective of this study is to determine whether a new minimally invasive method for in vivo measurement of cortical bone tissue properties can identify those who are at risk for fragility fractures of the hip and radius. The investigators hypothesis is that women with fragility fractures of the ...

What is the current status of trial NCT03076034?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2015-01-26. Estimated completion is 2028-11.

What conditions does trial NCT03076034 study?

This clinical trial studies the following conditions: Osteoporosis, Hip Fractures, Distal Radius Fracture.

What interventions are being tested in trial NCT03076034?

The interventions under investigation include: Reference Point Indentation (DEVICE).

Who is sponsoring clinical trial NCT03076034?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03076034 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoporosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.